1
The stone- free rate showed no significant differences between the two groups.
2
All stones were calcium oxalate and the stone free rate was 100%.
3
The FSB wants at least one risk- free rate by the second quarter of 2016.
4
The stone- free rate negatively correlated with stone size when adjusted for body mass index.
5
The primary endpoint was the progression- free rate at 16 weeks.
6
In contrast, SWL had the lowest success and stone- free rate.
7
Similar analysis for colectomy- free rate and severe adverse events demonstrated the same rank order of efficacy.
8
Conclusions: PCNL showed the highest success and stone- free rate in the surgical treatment of renal stones.
9
Conclusions: The 5-year event- free rate was not satisfying.
10
The outcomes were clinical response, colectomy free rate, and severe adverse events leading to discontinuation of therapy.
11
Main outcomes and measures: Six-month progression- free rate.
12
Conclusions: For general patients with kidney calculi, PCNL in supine position has similar stone- free rate compared with prone.
13
The primary endpoint for the phase II portion (RTKI resistant patients) was the 6-month progression- free rate.
14
The stone- free rate was 100% in both groups.
15
Relationships between stone size and the stone- free rate, operative time, complications, hospital stay and need for re-treatment were determined.
16
Bond turmoil signals new era of return- free risk Forget the risk- free rate - investment safe havens are in short supply.
